Publication: 4338

Publication: 4338

Improving risk stratification for 2022 European LeukemiaNet favorable-risk patients with acute myeloid leukemia

PubMed

PMC

QxMD

DOI

Google Scholar

Citation:: Innovation (Camb) vol 5 (6)

Year:: 2024
Type:: Manuscript
Funding:: NCTN
Endpoint:: Primary
Analysis:: Primary
Data Sharing:: Alliance-data-source,-internal-user
Status:: Presented/Published
Citation Status:: Received

Note:

Methodological:: No
Biospecimen:: Yes
SDC:: No
Book Volume:: 15

Parents:: 3826
Children:: None

Program:: OGC
Primary Committee:: Leukemia
Sec. Committees:

Pharmas:
Grants:: U10CA180821, U10CA180882, U24CA196171, R01LM013879, R01CA262496, R01CA284595, R01CA283574, UG1CA233327, UG1CA233331, UG1CA233338, UG1CA233339, R35CA197734, P30CA016058

Corr. Author:
Authors:: Kellie J. Archer Han Fu Krzysztof Mrózek Deedra Nicolet Alice S. Mims Geoffrey L. Uy Wendy Stock John C. Byrd Wolfgang Hiddemann Klaus H. Metzeler Christian Rausch Utz Krug Cristina Sauerland Dennis Görlich Wolfgang E. Berdel Bernhard J. Woermann Jan Braess Karsten Spiekermann Tobias Herold Ann-Kathrin Eisfeld

Networks:: LAPS-IL057, LAPS-MO011, LAPS-OH007, OH070

Study: Alliance-A152010
Multiple Studies, or Legacy Studies in Alliance Study:: CALGB-10503, CALGB-10603, CALGB-19808, CALGB-20202, CALGB-8461, CALGB-8525, CALGB-8721, CALGB-9222, CALGB-9621
Phases:: N/A, 1, 2, 3, N/A

Keywords: